Ignite Creation Date:
2025-12-24 @ 12:23 PM
Ignite Modification Date:
2025-12-27 @ 9:29 PM
Study NCT ID:
NCT02215161
Status:
TERMINATED
Last Update Posted:
2018-06-26
First Post:
2014-07-30
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Selinexor in Treating Patients With Abiraterone Acetate and/or Enzalutamide Refractory Metastatic Castration-Resistant Prostate Cancer
Sponsor:
University of California, San Francisco
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2014-09-02
Start Date Type:
ACTUAL
Primary Completion Date:
2017-02-15
Primary Completion Date Type:
ACTUAL
Completion Date:
2018-04-02
Completion Date Type:
ACTUAL
First Submit Date:
2014-07-30
First Submit QC Date:
None
Study First Post Date:
2014-08-13
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2018-04-26
Results First Submit QC Date:
None
Results First Post Date:
2018-06-26
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-05-29
Last Update Post Date:
2018-06-26
Last Update Post Date Type:
ACTUAL